Literature DB >> 14085968

CLINICAL TRIAL AND PHARMACOLOGICAL STUDY OF COMPOUND 1029. ("VATENSOL").

T D LAWRIE, A R LORIMER, S G MCALPINE, H REINERT.   

Abstract

Entities:  

Keywords:  ANTIHYPERTENSIVE AGENTS; DIURETICS; DOGS; DOSAGE FORMS; HYPERTENSION, MALIGNANT; HYPERTENSION, RENAL; NITROGEN; NOREPINEPHRINE; PHARMACOLOGY; SYMPATHOLYTICS; TOXICOLOGIC REPORT; URINE

Mesh：

Substances：

Year:  1964        PMID： 14085968      PMCID： PMC1813383          DOI： 10.1136/bmj.1.5380.402

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Treatment of hypertension in out-patients: mecamylamine, bretylium and guanethidine.

Authors:  R FIFE; F MORAN; J PRINEAS
Journal:  Scott Med J       Date:  1962-12       Impact factor: 0.729

2.  The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine.

Authors:  E Y LEVIN; B LEVENBERG; S KAUFMAN
Journal:  J Biol Chem       Date:  1960-07       Impact factor: 5.157

3.  An autoanalytical method for the estimation of adrenaline and noradrenaline.

Authors:  R J MERRILLS
Journal:  Nature       Date:  1962-03-10       Impact factor: 49.962
  3 in total
  3 in total

1.  Double-blind trial of four hypotensive drugs (methyldopa and three sympatholytic agents).

Authors:  V Vejlsgaard; M Christensen; E Clausen
Journal:  Br Med J       Date:  1967-06-03

2.  Methyldopa in hypertension.

Authors: 
Journal:  Br Med J       Date:  1966-01-15

3.  Guanoclor as an antihypertensive drug.

Authors:  J V Hodge
Journal:  Br Med J       Date:  1966-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.